Trial Profile
Lymph nodes with and without Alemtuzumab to measure broad alloreactivity against donor antigens.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2018
Price :
$35
*
At a glance
- Drugs Alemtuzumab (Primary)
- Indications Graft-versus-host disease
- Focus Pharmacodynamics
- Acronyms LAMBADA
- 10 May 2016 New trial record